• Japanese
  • Korean
  • Chinese
Cover Image

U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2012

The U.S. market for diabetes diagnosis, treatment and drug delivery is expected to exceed $17.87 billion by 2018.

The market segments covered in this report include:

  • traditional blood glucose meters,
  • continuous glucose monitoring systems,
  • blood glucose test strips,
  • lancets and lancing devices,
  • insulin,
  • insulin syringes,
  • insulin pens and
  • insulin pumps

Market growth is expected to be fueled by an increasing number of diabetics and improved education regarding the importance of blood glucose management. Factors such as high obesity rates, poor diet and lack of exercise will contribute to the growing type 2 diabetic population.

Market growth for diabetes diagnosis, treatment and drug delivery will be led by double-digit growth in the continuous glucose monitor, insulin pen and insulin pump segments.

Within the diabetes diagnosis, treatment and drug deliver market, companies such as Novo Nordisk, Sanofi, Eli Lilly and Lifescan lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1. U.S. DIABETES DIAGNOSIS, TREATMENT AND DRUG DELIVERY MARKET
  • 1.2. GROWTH TRENDS BY SEGMENT
  • 1.3. BLOOD GLUCOSE MONITORING MARKET
  • 1.4. INSULIN MARKET
  • 1.5. INSULIN SYRINGE MARKET
  • 1.6. INSULIN PEN MARKET
  • 1.7. INSULIN PUMP MARKET
  • 1.8. COMPETITIVE ANALYSIS

RESEARCH METHODOLOGY

  • 2.1. RESEARCH SCOPE
  • 2.2. IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

U.S. DIABETES DIAGNOSIS, TREATEMENT AND DRUG DELIVERY MARKET

  • 3.1. INTRODUCTION
    • 3.1.1. Types of Diabetes
      • 3.1.1.1. Type 1 Diabetes
      • 3.1.1.2. Type 2 Diabetes
      • 3.1.1.3. Gestational Diabetes
      • 3.1.1.4. Prediabetes
    • 3.1.2. Diabetes Complications
    • 3.1.3. Risk Factors Associated with Type I and Type 2 Diabetes
    • 3.1.4. Signs and Symptoms
    • 3.1.5. Diabetes Monitoring
      • 3.1.5.1. Initial Diagnosis
      • 3.1.5.2. Blood Glucose Monitoring Systems
      • 3.1.5.3. Urinary Glucose Monitoring
      • 3.1.5.4. Noninvasive and Minimally Invasive Monitoring Devices
    • 3.1.6. Treatment
      • 3.1.6.1. Lifestyle Measures
      • 3.1.6.2. Insulin
      • 3.1.6.3. Oral Antidiabetic Drugs
      • 3.1.6.4. Injectable Antidiabetic Drugs
    • 3.1.7. Drug Delivery Systems
      • 3.1.7.1. Insulin Syringes
      • 3.1.7.2. Insulin Pens
      • 3.1.7.3. Insulin Pumps
      • 3.1.7.4. Inhaled Insulin
  • 3.2. MARKET OVERVIEW
  • 3.3. TREND ANALYSIS BY MARKET SEGMENT
  • 3.4. MARKET DRIVERS AND LIMITERS
    • 3.4.1. Market Drivers
    • 3.4.2. Market Limiters
  • 3.5. COMPETITIVE ANALYSIS
    • 3.5.1. Market Concentration
  • 3.6. MERGERS AND ACQUISITIONS

TRADITIONAL BLOOD GLUCOSE METER MARKET

  • 4.1. INTRODUCTION
  • 4.2. MARKET OVERVIEW
  • 4.3. MARKET ANALYSIS AND FORECAST
    • 4.3.1. Professional Blood Glucose Meter Market
    • 4.3.2. Personal Blood Glucose Meter Market
  • 4.4. MARKET DRIVERS AND LIMITERS
    • 4.4.1. Market Drivers
    • 4.4.2. Market Limiters
  • 4.5. COMPETITIVE ANALYSIS

CONTINUOUS GLUCOSE MONITORING MARKET

  • 5.1. INTRODUCTION
  • 5.2. MARKET OVERVIEW
    • 5.2.1. Total Continuous Glucose Monitoring Market
    • 5.2.2. Emerging Markets: Intravascular Continuous Glucose Monitoring
  • 5.3. MARKET ANALYSIS AND FORECAST
    • 5.3.1. Total CGM Market
  • 5.4. MARKET DRIVERS AND LIMITERS
    • 5.4.1. Market Drivers
    • 5.4.2. Market Limiters
  • 5.5. COMPETITIVE ANALYSIS

BLOOD GLUCOSE TEST STRIP MARKET

  • 6.1. INTRODUCTION
  • 6.2. MARKET OVERVIEW
  • 6.3. MARKET ANALYSIS AND FORECAST
    • 6.3.1. Professional Blood Glucose Test Strip Market
    • 6.3.2. Personal Blood Glucose Test Strip Market
  • 6.4. MARKET DRIVERS AND LIMITERS
    • 6.4.1. Market Drivers
    • 6.4.2. Market Limiters
  • 6.5. COMPETITIVE ANALYSIS

LANCET AND LANCING DEVICE MARKET

  • 7.1. INTRODUCTION
  • 7.2. MARKET OVERVIEW
  • 7.3. MARKET ANALYSIS AND FORECAST
    • 7.3.1. Professional Lancet and Lancing Device Market
    • 7.3.2. Personal Lancet and Lancing Device Market
  • 7.4. MARKET DRIVERS AND LIMITERS
    • 7.4.1. Market Drivers
    • 7.4.2. Market Limiters
  • 7.5. COMPETITIVE ANALYSIS

INSULIN MARKET

  • 8.1. INTRODUCTION
    • 8.1.1. Insulin Types
  • 8.2. MARKET OVERVIEW
  • 8.3. MARKET ANALYSIS AND FORECAST
  • 8.4. MARKET DRIVERS AND LIMITERS
    • 8.4.1. Market Drivers
    • 8.4.2. Market Limiters
  • 8.5. COMPETITIVE ANALYSIS

INSULIN SYRINGE MARKET

  • 9.1. INTRODUCTION
  • 9.2. MARKET OVERVIEW
  • 9.3. MARKET ANALYSIS AND FORECAST
    • 9.3.1. Professional Insulin Syringe Market
    • 9.3.2. Personal Insulin Syringe Market
  • 9.4. MARKET DRIVERS AND LIMITERS
    • 9.4.1. Market Drivers
    • 9.4.2. Market Limiters
  • 9.5. COMPETITIVE ANALYSIS

INSULIN PEN MARKET

  • 10.1. INTRODUCTION
  • 10.2. MARKET ANALYSIS AND FORECAST
  • 10.3. MARKET DRIVERS AND LIMITERS
    • 10.3.1. Market Drivers
    • 10.3.2. Market Limiters
  • 10.4. COMPETITIVE ANALYSIS

INSULIN PUMP MARKET

  • 11.1. INTRODUCTION
  • 11.2. MARKET OVERVIEW
  • 11.3. MARKET ANALYSIS AND FORECAST
    • 11.3.1. Total Traditional Insulin Pump Market
      • 11.3.1.1. Traditional Pump Market
      • 11.3.1.2. Infusion Set Market
    • 11.3.2. Total Patch Pump Market
      • 11.3.2.1. Patch Pump Controller Market
      • 11.3.2.2. Insulin Pod Market
    • 11.3.3. Simple Pump Market
  • 11.4. MARKET DRIVERS AND LIMITERS
    • 11.4.1. Market Drivers
    • 11.4.2. Market Limiters
  • 11.5. COMPETITIVE ANALYSIS
    • 11.5.1.1. Emerging Competitors

APPENDIX 1: EMERGING MARKETS & ALTERNATIVE THERAPIES

  • 12.1. ARTIFICIAL PANCREAS
    • 12.1.1. Mechanical Artificial Pancreas
    • 12.1.2. Bio-Artificial Pancreas
  • 12.2. NEEDLESS INJECTORS

ABBREVIATIONS

Show More
RELATED REPORTS
* Infusion Pumps & Accessories Market by Product (Volumetric, Syringe, Enteral, Insulin, Implantable, PCA Pump), Application (Diabetes, Chemotherapy, Nutrition, Pain Management) & by End-user (Hospital, Home Healthcare) - Global Forecasts to 2018
  • Published:
  • Apr 01, 2014
  • USD 4650
  • 372 Pages

* Europe Diabetes Management Market Reports, 2005 - 2018
  • Published:
  • Sep 23, 2013
  • USD 4200
  • 110 Pages

* mhealth Apps & Solutions Market By Connected Devices (Cardiac Monitoring, Diabetes Management Devices), Health Apps (Exercise, Weight Loss, Women's Health, Sleep and Meditation), Medical Apps (Medical Reference) - Global Trends & Forecast to 2018
  • Published:
  • Sep 09, 2013
  • USD 4650
  • 277 Pages

* In Vitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics) - Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018
  • Published:
  • Jul 31, 2013
  • USD 4595
  • 124 Pages

* European Injectable Drug Delivery Market By Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Forecasts to 2017
  • Published:
  • Jul 05, 2013
  • USD 4650
  • 333 Pages

* Advanced Wound Management Market to 2019 - Increasing Incidence of Diabetes Leading to Chronic Wounds in Emerging Countries will Drive Future Growth
  • Published:
  • Jun 03, 2013
  • USD 3500
  • 130 Pages

* North America Injectable Drug Delivery Market - by Formulations (Liposomes, Microspheres & Nanoparticles), Devices (Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors) & Therapeutics (Diabetes & Oncology) - Forecasts to 2017
  • Published:
  • Apr 08, 2013
  • USD 4650
  • 280 Pages

* Global Markets for Diabetes Therapeutics and Diagnostics
  • Published:
  • Jan 01, 2013
  • USD 6650
  • 167 Pages

* US Markets for Diabetes Care Devices 2013
  • Published:
  • Dec 19, 2012
  • USD 6495

* Global Diabetes Devices Market And Diabetes Drugs Market - Industry Scenario, Trends, Analysis, Size, Share & Forecast 2011 - 2018
  • Published:
  • Dec 05, 2012
  • USD 4395
  • 162 Pages

Browse more Patient Monitoring Market Research Reports

Pricing
Get Notified
Email me when related reports are published